No Data
No Data
Cyclopharm Limited's (ASX:CYC) Last Week's 13% Decline Must Have Disappointed Retail Investors Who Have a Significant Stake
Cyclopharm Raises AU$20 Million Share Placement for Technegas Commercialization; Shares Down 16%
Cyclopharm (ASX:CYC) completed its institutional placement of 14.1 million new shares at AU$1.42 per share, raising AU$20 million, according to a Monday filing with the Australian Securities Exchange.
Cyclopharm Price Target Cut 11% to A$3.40/Share by Bell Potter
Cyclopharm Price Target Cut 11% to A$3.40/Share by Bell Potter
Cyclopharm Limited's (ASX:CYC) Profit Outlook
Cyclopharm's (ASX:CYC) Investors Will Be Pleased With Their Respectable 53% Return Over the Last Five Years
Cyclopharm (ASX:CYC) Is In A Strong Position To Grow Its Business
No Data